Biotech · Public company · Wilmington, DE, US
Prelude Therapeutics Inc
Ticker PRLD · SEC CIK 0001678660
Track this companyFree. Adds Prelude Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials132 recruiting or active
Pipeline programs21From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline21
- pembrolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PRT3789Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AbemaciclibPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- ImlunestrantPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PRT12396Phase 1 · Polycythemia Vera (PV)ClinicalTrials.gov · fetched Nov 12, 2026
- PRT13722Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PRT1419Phase 1 · SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- PRT1419Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- PRT1419Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- PRT2527Phase 1 · SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- PRT2527Phase 1 · Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)ClinicalTrials.gov · fetched Nov 12, 2026
- PRT3645Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PRT543Phase 1 · Relapsed/Refractory Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PRT7732Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PRT811Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 1 · Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)ClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 1 · Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast CancerPHASE1 · RECRUITING · started Nov 16, 2026ClinicalTrials.gov NCT07905001 · fetched Nov 12, 2026
- A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative NeoplasmsPHASE1 · RECRUITING · started Apr 29, 2026ClinicalTrials.gov NCT07469891 · fetched Nov 12, 2026
- A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationPHASE2 · TERMINATED · started Jun 3, 2025ClinicalTrials.gov NCT06682806 · fetched Nov 12, 2026
- A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationPHASE1 · TERMINATED · started Nov 4, 2024ClinicalTrials.gov NCT06560645 · fetched Nov 12, 2026
- A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic MalignanciesPHASE1 · COMPLETED · started Sep 12, 2023ClinicalTrials.gov NCT05665530 · fetched Nov 12, 2026
- PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationPHASE1 · COMPLETED · started May 2, 2023ClinicalTrials.gov NCT05639751 · fetched Nov 12, 2026
- A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsPHASE1 · COMPLETED · started Dec 27, 2022ClinicalTrials.gov NCT05538572 · fetched Nov 12, 2026
- PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesPHASE1 · TERMINATED · started Mar 22, 2022ClinicalTrials.gov NCT05107856 · fetched Nov 12, 2026
- A Study of PRT2527 in Participants With Advanced Solid TumorsPHASE1 · COMPLETED · started Feb 14, 2022ClinicalTrials.gov NCT05159518 · fetched Nov 12, 2026
- A Study of PRT1419 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Aug 11, 2021ClinicalTrials.gov NCT04837677 · fetched Nov 12, 2026
- A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic MalignanciesPHASE1 · COMPLETED · started Sep 28, 2020ClinicalTrials.gov NCT04543305 · fetched Nov 12, 2026
- A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and GliomasPHASE1 · COMPLETED · started Nov 6, 2019ClinicalTrials.gov NCT04089449 · fetched Nov 12, 2026
- A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesPHASE1 · COMPLETED · started Feb 11, 2019ClinicalTrials.gov NCT03886831 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 21, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026